Literature DB >> 11744694

Nuclear localization of Duplin, a beta-catenin-binding protein, is essential for its inhibitory activity on the Wnt signaling pathway.

Masashi Kobayashi1, Shosei Kishida, Akimasa Fukui, Tatsuo Michiue, Yoichi Miyamoto, Tetsuji Okamoto, Yoshihiro Yoneda, Makoto Asashima, Akira Kikuchi.   

Abstract

Duplin binds to beta-catenin and inhibits the Wnt signaling pathway, thereby leading to repression of the beta-catenin-mediated transactivation and Xenopus axis formation. To find an additional function of Duplin, yeast two-hybrid screening was carried out. Importin alpha was isolated as a binding protein of Duplin. Importin alpha bound directly to basic amino acid clusters of Duplin. Although Duplin was present in the nucleus, deletion of the basic amino acid clusters (Duplin(Delta 500-584)) retained Duplin in the cytoplasm. Duplin(Delta 500-584) bound to beta-catenin as efficiently as wild-type Duplin, but it neither repressed Wnt-dependent Tcf transcriptional activation in mammalian cells nor showed ventralization in Xenopus embryos. The Duplin mutant without a beta-catenin-binding region lost the ability to inhibit the Wnt-dependent Tcf activation, but retained its ventralizing activity. Furthermore, Duplin not only suppressed beta-catenin-dependent axis duplication and expression of siamois, a Wnt-regulated gene, but also inhibited siamois-dependent axis duplication. These results indicate that Duplin is translocated to the nucleus by interacting with importin alpha, and that nuclear localization is essential for the function of Duplin. Moreover, Duplin has an additional activity of inhibiting the Wnt signaling pathway by affecting the downstream beta-catenin target genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744694     DOI: 10.1074/jbc.M108433200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes.

Authors:  Brandi A Thompson; Véronique Tremblay; Grace Lin; Daniel A Bochar
Journal:  Mol Cell Biol       Date:  2008-03-31       Impact factor: 4.272

Review 2.  Advances of Wnt signalling pathway in dental development and potential clinical application.

Authors:  Xi Lu; Jun Yang; Shouliang Zhao; Shangfeng Liu
Journal:  Organogenesis       Date:  2019-09-04       Impact factor: 2.500

Review 3.  Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance.

Authors:  Zhaowei Tu; Yi Zheng
Journal:  Curr Opin Hematol       Date:  2022-02-18       Impact factor: 3.218

4.  Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action.

Authors:  Atefeh Rabiee; Marcus Krüger; Jacob Ardenkjær-Larsen; C Ronald Kahn; Brice Emanuelli
Journal:  Cell Signal       Date:  2018-03-14       Impact factor: 4.315

5.  Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.

Authors:  Sahrunizam Kasah; Christopher Oddy; M Albert Basson
Journal:  J Anat       Date:  2018-10-02       Impact factor: 2.610

6.  Early embryonic death in mice lacking the beta-catenin-binding protein Duplin.

Authors:  Masaaki Nishiyama; Keiko Nakayama; Ryosuke Tsunematsu; Tadasuke Tsukiyama; Akira Kikuchi; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  Chromodomain helicase binding protein 8 (Chd8) is a novel A-kinase anchoring protein expressed during rat cardiac development.

Authors:  Maureen O Shanks; Linda M Lund; Sabrina Manni; Mary Russell; Joseph R H Mauban; Meredith Bond
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

8.  Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling.

Authors:  Omer Durak; Fan Gao; Yea Jin Kaeser-Woo; Richard Rueda; Anthony J Martorell; Alexi Nott; Carol Y Liu; L Ashley Watson; Li-Huei Tsai
Journal:  Nat Neurosci       Date:  2016-10-03       Impact factor: 24.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.